The global cluster headache treatment market is estimated to grow at a CAGR of around 6% during the forecast period. The major factors contributing to the growth of the market include the growing geriatric population and the increasing number of cases of cluster headache syndrome. Additionally, increase in the usage of computers, laptops, and smartphones for personal as well as professional purposes among people rising the cases of cluster headache syndrome, hence increasing the demand for drugs and devices for pain management. According to World Health Organization (WHO) report, one in thousand adults is suffering from cluster headache and it is more prone to affect men as compared to women, affecting around six men to each woman.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/cluster-headache-treatment-market

Rising demand for cluster headache disorder solutions and the availability of skilled professionals in hospitals and clinics are key attributes leading to the increasing growth of the cluster headache treatment market. Moreover, the increasing number of multi-specialty hospitals in developed and developing countries and growing awareness among people toward health are further strengthening the cluster headache treatment market. New developments and technological advancements in the healthcare sector propelling the growth of the cluster headache treatment market. For instance, in June 2019, the US Food and Drug Administration (FDA) announced the approval of the Emgality (galcanezumab) solution for injection that is designed with the aim of treatment of episodic headache in adults. The approval is granted to Eli Lilly by the FDA for the better treatment of cluster headache. The drug reduces the frequency of attacks of episodic cluster headache.

A Full Report of Cluster Headache Treatment Market Market is Available at: https://www.omrglobal.com/industry-reports/cluster-headache-treatment-market

The global cluster headache treatment market is segmented based on drugs and devices. Based on drug type, the market is classified into triptans, octreotide, dihydroergotamine, and others. The continuous efforts to develop innovative devices for managing cluster headache is driving the growth of the device segment. For instance, in November 2018, ElectroCore, Inc. received FDA approval for an expanded label for gammaCore [non-invasive vagus nerve stimulator (nVNS)] therapy for adjunctive use for the preventive treatment of cluster headache in adult patients. However, the drug segment held the highest market share owing to the easy availability and comparatively low cost than nerve stimulators. The drugs are available at hospital clinics, private clinics, and retail pharmacies.

Market Segmentation
Global Cluster Headache Treatment Market by Treatment
 Drugs
• Triptans
• Octreotide
• Dihydroergotamine
• Others (Local Anesthetics)
 Devices

Segment by Region
North America
• United States
• Canada

Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World
• Latin America
• Middle East and Africa

Company Profiles
• AstraZeneca PLC
• Aurobindo Pharma, Ltd.
• Autonomic Technologies, Inc.
• Dr. Reddy's Laboratories, Ltd.
• ElectroCore Medical LLC
• Eli Lilly and Company
• Fresenius Kabi Pharmaceuticals Holding, Inc.
• GlaxoSmithKline PLC
• Janssen Pharmaceuticals, Inc.
• LGM Pharma, LLC
• Merck KGaA
• Mylan N.V.
• Novartis AG
• Par Pharmaceutical Companies, Inc.
• Ranbaxy Laboratories, Ltd.
• Sagent Pharmaceuticals, Inc.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• TrioxBio Inc.
• Winston Pharmaceuticals Inc.


For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/cluster-headache-treatment-market

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 780-304-0404